3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Congenital Abnormalities
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumor, Pleural
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Melanoma
1
Malignant Tumor of Ill-defined Site
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Interventions
Dexamethasone
2
Azacitidine
2
sacubitril and valsartan sodium hydrate drug combination
1
regorafenib
1
pevonedistat
1
melflufen
1
glucarpidase
1
gamma-Glutamyl Hydrolase
1
copanlisib
1
carfilzomib
1
Thalidomide
1
Methotrexate
1
Leucovorin
1
L-melphalanyl-p-L-fluorophenylalanine ethyl ester
1
Cyclophosphamide
1
Bortezomib
1
Bendamustine Hydrochloride
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Renal Insufficiency
×
Pharmacogenomic Testing
×
Clear all
No trials found.